Biotech

HUB CART Investment is focused on offering small, micro, and medium-sized companies (SMMEs), the public sector, and large corporate organizations high-quality services both locally and internationally.

Our primary focus is on creating and putting into practice innovative, personalized, and effective service delivery techniques that are affordable for our customers.

The company, a level 3 BEE contributor, is based in Windhoek, Namibia, and is a member of the Construction and National Association of Black Contractors (NABCAT).

Grabouw Based operation.   We use the dual thrust of Hydro Power and Industrial Hemp to bring Economic opportunity to the greater population of the Grabouw Valley

With the Plentiful river structure and a large number of dams, we are working with the Large Scale Apple Farmers and Fruit juice producers to identify and develop a local electricity grid, the benefits of this are twofold: Dependable low-cost electricity and significant improvement in Grabouw Carbon Footprint.

Industrial hemp has multiple benefits. Firstly drawdown,  with a drawdown rate of approximately 20 tons of toxic gas per

4Di Capital is a venture capital fund manager focused on high-growth technology venture opportunities in the Southern and Eastern Africa region.

4Di Capital is an independent venture capital fund manager based in South Africa’s “Silicon Cape”, specialising in high-growth technology venture opportunities, at the seed, early-and growth-funding stages. The fund manager has offices in Cape Town, South Africa and Atlanta, Georgia, U.S.A. and funds are managed by the GP partnership team of Anton van Vlaanderen, Erik van Vlaanderen, Justin Stanford and Laurie Olivier.

eGolibio is a South African life science incubator supporting SMEs with products and business development. It supports enterprises in the life science sector with product refinement, market access, networking, training and access to funding.

Its activities are aligned with the Department of Science and innovation (DSI) National Biotechnology Strategy (NBS) in the development of the bioeconomy.

The NBS reflects the government's commitment to biotechnology as an important source of future economic growth and is aligned with many developing and developed countries which invest heavily in